chr3-49510754-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000308775.7(DAG1):c.220G>A(p.Val74Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000107 in 1,614,174 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V74A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000308775.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DAG1 | NM_004393.6 | c.220G>A | p.Val74Ile | missense_variant | 2/3 | ENST00000308775.7 | NP_004384.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DAG1 | ENST00000308775.7 | c.220G>A | p.Val74Ile | missense_variant | 2/3 | 1 | NM_004393.6 | ENSP00000312435 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152176Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.000143 AC: 36AN: 251266Hom.: 1 AF XY: 0.000103 AC XY: 14AN XY: 135814
GnomAD4 exome AF: 0.000109 AC: 160AN: 1461880Hom.: 0 Cov.: 75 AF XY: 0.000102 AC XY: 74AN XY: 727246
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152294Hom.: 1 Cov.: 31 AF XY: 0.0000671 AC XY: 5AN XY: 74478
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2P Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 20, 2015 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 15, 2021 | - - |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9;C4511963:Autosomal recessive limb-girdle muscular dystrophy type 2P Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 03, 2022 | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 74 of the DAG1 protein (p.Val74Ile). This variant is present in population databases (rs189360006, gnomAD 0.1%). This missense change has been observed in individual(s) with clinical features of muscular dystrophy-dystroglycanopathy (PMID: 25503980). ClinVar contains an entry for this variant (Variation ID: 208540). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies have shown that this missense change affects DAG1 function (PMID: 25503980). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at